Background: Recovery from acute COVID-19 may be slow and incomplete: cases of Post-Acute Sequelae of COVID (PASC) are counted in millions, worldwide. We aimed to explore if and how the pre-existing Socio-economic-status (SES) influences such recovery. Methods: We analyzed a database of 1536 consecutive patients from the first wave of COVID-19 in Italy (February-September 2020), previously admitted to our referral hospital, and followed-up in a dedicated multidisciplinary intervention. We excluded those seen earlier than 12 weeks (the conventional limit for a possible PASC syndrome), and those reporting a serious complication from the acute phase (possibly accounting for symptoms persistence). We studied whether the exposition to disadvantaged SES (estimated through the Italian Institute of Statistics’s model – ISTAT 2017) was affecting recovery outcomes, that is: symptoms (composite endpoint, i.e. at least one among: dyspnea, fatigue, myalgia, chest pain or palpitations); Health-Related-Quality-of-Life (HRQoL, as by SF-36 scale); post-traumatic-stress-disorder (as by IES-R scale); and lung structural damage (as by impaired CO diffusion, DLCO). Results: Eight-hundred and twenty-five patients were included in the analysis (median age 59 years; IQR: 50–69 years, 60.2% men), of which 499 (60.5%) were previously admitted to hospital and 27 (3.3%) to Intensive-Care Unit (ICU). Those still complaining of symptoms at follow-up were 337 (40.9%; 95%CI 37.5–42.2%), and 256 had a possible Post-Traumatic Stress Disorder (PTSD) (31%, 95%CI 28.7–35.1%). DLCO was reduced in 147 (19.6%, 95%CI 17.0–22.7%). In a multivariable model, disadvantaged SES was associated with a lower HRQoL, especially for items exploring physical health (Limitations in physical activities: OR = 0.65; 95%CI = 0.47 to 0.89; p = 0.008; AUC = 0.74) and Bodily pain (OR = 0.57; 95%CI = 0.40 to 0.82; p = 0.002; AUC = 0.74). We did not observe any association between SES and the other outcomes. Conclusions: Recovery after COVID-19 appears to be independently affected by a pre-existent socio-economic disadvantage, and clinical assessment should incorporate SES and HRQoL measurements, along with symptoms. The socioeconomic determinants of SARS-CoV-2 disease are not exclusive of the acute infection: this finding deserves further research and specific interventions.

Socio-economic conditions affect health-related quality of life, during recovery from acute SARS-CoV-2 infection: Results from the VASCO study (VAriabili Socioeconomiche e COVID-19), on the “Surviving-COVID” cohort, from Bergamo (Italy) / Benatti, S. V.; Venturelli, S.; Buzzetti, R.; Binda, F.; Belotti, L.; Soavi, L.; Biffi, A. M.; Spada, M. S.; Casati, M.; Rizzi, M.; Zuglian, G.; Zucchi, A.; Zanoletti, A.; Suardi, C.; Severgnini, R.; Sessa, M.; Seghezzi, M.; Rossini, A.; Quinzan, G.; Previtali, G.; Pellegrini, R.; Ouabou, A.; Marinaro, C.; Marchetti, M.; Imeri, G.; Greco, G.; Giammarresi, A.; Ghirardi, A.; Gerevini, S.; Falanga, A.; Crotti, G.; Cosentini, R.; Conti, C.; Cesa, S.; Carobbio, A.; Carioli, G.; Camera, G.; Bondi, E.; Bonaffini, P. A.; Barbui, T.; Ambaglio, C.; Alessio, M. G.. - In: BMC INFECTIOUS DISEASES. - ISSN 1471-2334. - 24:1(2024), pp. 815-815. [10.1186/s12879-024-09502-x]

Socio-economic conditions affect health-related quality of life, during recovery from acute SARS-CoV-2 infection: Results from the VASCO study (VAriabili Socioeconomiche e COVID-19), on the “Surviving-COVID” cohort, from Bergamo (Italy)

Carobbio A.;
2024

Abstract

Background: Recovery from acute COVID-19 may be slow and incomplete: cases of Post-Acute Sequelae of COVID (PASC) are counted in millions, worldwide. We aimed to explore if and how the pre-existing Socio-economic-status (SES) influences such recovery. Methods: We analyzed a database of 1536 consecutive patients from the first wave of COVID-19 in Italy (February-September 2020), previously admitted to our referral hospital, and followed-up in a dedicated multidisciplinary intervention. We excluded those seen earlier than 12 weeks (the conventional limit for a possible PASC syndrome), and those reporting a serious complication from the acute phase (possibly accounting for symptoms persistence). We studied whether the exposition to disadvantaged SES (estimated through the Italian Institute of Statistics’s model – ISTAT 2017) was affecting recovery outcomes, that is: symptoms (composite endpoint, i.e. at least one among: dyspnea, fatigue, myalgia, chest pain or palpitations); Health-Related-Quality-of-Life (HRQoL, as by SF-36 scale); post-traumatic-stress-disorder (as by IES-R scale); and lung structural damage (as by impaired CO diffusion, DLCO). Results: Eight-hundred and twenty-five patients were included in the analysis (median age 59 years; IQR: 50–69 years, 60.2% men), of which 499 (60.5%) were previously admitted to hospital and 27 (3.3%) to Intensive-Care Unit (ICU). Those still complaining of symptoms at follow-up were 337 (40.9%; 95%CI 37.5–42.2%), and 256 had a possible Post-Traumatic Stress Disorder (PTSD) (31%, 95%CI 28.7–35.1%). DLCO was reduced in 147 (19.6%, 95%CI 17.0–22.7%). In a multivariable model, disadvantaged SES was associated with a lower HRQoL, especially for items exploring physical health (Limitations in physical activities: OR = 0.65; 95%CI = 0.47 to 0.89; p = 0.008; AUC = 0.74) and Bodily pain (OR = 0.57; 95%CI = 0.40 to 0.82; p = 0.002; AUC = 0.74). We did not observe any association between SES and the other outcomes. Conclusions: Recovery after COVID-19 appears to be independently affected by a pre-existent socio-economic disadvantage, and clinical assessment should incorporate SES and HRQoL measurements, along with symptoms. The socioeconomic determinants of SARS-CoV-2 disease are not exclusive of the acute infection: this finding deserves further research and specific interventions.
2024
24
1
815
815
Socio-economic conditions affect health-related quality of life, during recovery from acute SARS-CoV-2 infection: Results from the VASCO study (VAriabili Socioeconomiche e COVID-19), on the “Surviving-COVID” cohort, from Bergamo (Italy) / Benatti, S. V.; Venturelli, S.; Buzzetti, R.; Binda, F.; Belotti, L.; Soavi, L.; Biffi, A. M.; Spada, M. S.; Casati, M.; Rizzi, M.; Zuglian, G.; Zucchi, A.; Zanoletti, A.; Suardi, C.; Severgnini, R.; Sessa, M.; Seghezzi, M.; Rossini, A.; Quinzan, G.; Previtali, G.; Pellegrini, R.; Ouabou, A.; Marinaro, C.; Marchetti, M.; Imeri, G.; Greco, G.; Giammarresi, A.; Ghirardi, A.; Gerevini, S.; Falanga, A.; Crotti, G.; Cosentini, R.; Conti, C.; Cesa, S.; Carobbio, A.; Carioli, G.; Camera, G.; Bondi, E.; Bonaffini, P. A.; Barbui, T.; Ambaglio, C.; Alessio, M. G.. - In: BMC INFECTIOUS DISEASES. - ISSN 1471-2334. - 24:1(2024), pp. 815-815. [10.1186/s12879-024-09502-x]
Benatti, S. V.; Venturelli, S.; Buzzetti, R.; Binda, F.; Belotti, L.; Soavi, L.; Biffi, A. M.; Spada, M. S.; Casati, M.; Rizzi, M.; Zuglian, G.; Zucch...espandi
File in questo prodotto:
File Dimensione Formato  
s12879-024-09502-x.pdf

Open access

Tipologia: VOR - Versione pubblicata dall'editore
Licenza: [IR] creative-commons
Dimensione 1.63 MB
Formato Adobe PDF
1.63 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1365435
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 2
social impact